Overview

Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

Status:
Completed
Trial end date:
2015-12-23
Target enrollment:
Participant gender:
Summary
The purpose of the study is to study the effects of BMS-955176 on the single-dose PK parameters of probe substrates caffeine, metoprolol, montelukast, flurbiprofen, omeprazole, midazolam, digoxin, and pravastatin
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
ViiV Healthcare
Treatments:
BMS-955176